Schering Faces Antitrust Suit Over Albuterol Prices
Schering Corp. has been hit with a lawsuit accusing the drugmaker of reporting inflated prices for albuterol to Medicaid in violation of the False Claims Act and federal anti-kickback laws in...To view the full article, register now.
Already a subscriber? Click here to view full article